Ameriprise’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ameriprise’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,891	Closed	-$282K	–	4042
2022 Q4	$282K	Sell	6,891 -51,419	-88%	-$2.14M	﹤0.01%	3607
2022 Q3	$2.34M	Sell	58,310 -36,240	-38%	-$1.55M	﹤0.01%	2715
2022 Q2	$3.32M	Buy	+94,550	New	+$3.97M	﹤0.01%	2559
2021 Q2	–	Sell	-34,888	Closed	-$1.76M	–	3972
2021 Q1	$1.76M	Buy	34,888 +3,911	+13%	+$208K	﹤0.01%	2908
2020 Q4	$1.61M	Sell	30,977 -14,047	-31%	-$672K	﹤0.01%	2887
2020 Q3	$1.96M	Buy	45,024 +12,362	+38%	+$542K	﹤0.01%	2682
2020 Q2	$1.4M	Buy	+32,662	New	+$1.35M	﹤0.01%	2769
2018 Q4	–	Sell	-4,187	Closed	-$203K	–	3778
2018 Q3	$203K	Buy	+4,187	New	+$198K	﹤0.01%	3543
2015 Q1	–	Sell	-7,188	Closed	-$388K	–	3945
2014 Q4	$388K	Buy	7,188 +5,836	+432%	+$319K	﹤0.01%	3220
2014 Q3	$70K	Sell	1,352 -112	-8%	-$5.69K	﹤0.01%	3846
2014 Q2	$76K	Sell	1,464 -2,668	-65%	-$129K	﹤0.01%	3714
2014 Q1	$193K	Buy	4,132 +2,130	+106%	+$101K	﹤0.01%	3256
2013 Q4	$88K	Sell	2,002 -140	-7%	-$5.83K	﹤0.01%	3436
2013 Q3	$82K	Buy	2,142 +1,546	+259%	+$58.5K	﹤0.01%	3551
2013 Q2	$21K	Buy	+596	New	+$20.1K	﹤0.01%	4254

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Ameriprise's XPH Position: Q1 2023 in Review

Ameriprise sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2023, closing a stake of 6,891 shares — an estimated $282K sold.

Ameriprise first reported a position in XPH in Q2 2013 and held it in 15 quarters. The position peaked at $3.32M in Q2 2022. 61 funds tracked by Wall St. Rank hold XPH as of Q1 2023.

Ameriprise reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
Ameriprise sold 6,891 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2023, an estimated $282K.
Ameriprise first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 15 quarters.
Ameriprise's State Street SPDR S&P Pharmaceuticals ETF position peaked at $3.32M in Q2 2022.
61 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2023.

Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.